Differentiating Parkinson’s disease dementia and mild cognitive impairment from idiopathic Parkinson’s disease using machine learning approach
Objective: This paper aims at creating a computer-based diagnosis tool which can predict the classification of MCI and dementia in patients of Parkinson's disease (PD)…Predicting dementia in the first 6 years of Parkinson’s disease in the ICICLE-PD cohort
Objective: To determine which baseline cognitive tests in newly diagnosed participants with Parkinson’s disease (PD) predict conversion to dementia (PDD) within six years. Background: Cognitive…Does constipation predict cognitive impairment and dementia in de novo Parkinson’s disease patients? A multi-cohort longitudinal data analysis
Objective: To investigate if constipation predicts the development of cognitive impairment (CI) and dementia in de novo Parkinson’s disease (PD). Background: Constipation is one of…Short digitalized cognitive test help differentiating Parkinson’s disease (PD) patients with and without Mild Cognitive Impairment (MCI)
Objective: We explored the capacity of a new digitalized multi-domain cognitive battery, to differentiate PD patients with MCI from those without MCI. Background: MCI is…Odor Identification as a Biomarker of Incident Cognitive Impairment and its Correlation with Neuropathology in the Rush MAP
Objective: Evaluate the neuropathological correlates and prospective incident cognitive and motor changes associated with odor identification (OI) in cognitively normal (CN) subjects. Background: Hyposmia is…Parkinson’s Disease Clinical Subtypes: Symptom Progression, Dementia, and Mortality
Objective: Identify Parkinson's disease (PD) clinical subtypes using multi-domain classification; determine subtype symptom progression; assess subtype clinical utility. Background: People with PD present with combinations…Vascular factors in Parkinson’s disease with cognitive impairment
Objective: To review the relationship between vascular related factors and cognitive impairment in Parkinson's disease. Background: Parkinson's disease is a chronic, progressive, neurodegenerative disease that…Increased neurofilament light chain plasma levels as a biological marker of mild cognitive impairment in Parkinson’s disease
Objective: To examine whether PD-MCI patients have increased plasma neurofilament light chain (NfL) levels compared to PD with normal cognition (PD-NC) and healthy controls (HC).…Mental Health Matters Too – Integration of physical and mental health in a multidisciplinary Parkinson’s Clinic
Objective: The overall aim of the project was to demonstrate that people with Parkinson’s disease benefit from good mental health care when mental health services…Clinical outcomes after DBS surgery in cognitively impaired patients with PD
Objective: To describe clinical outcomes after DBS in patients with PD and moderate cognitive impairment (CI). Background: DBS is generally contraindicated in PD patients with…
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 36
- Next Page »